Canary Global

Canary Global is a pioneering biotechnology company focused on developing innovative RNA therapies to address metabolic diseases, particularly obesity, and rare genetic disorders. Their flagship product, CCT-217, utilizes novel gene silencing technology to promote sustainable weight loss while preserving lean body mass, offering an advanced treatme... nt option for individuals with obesity. The company's mission emphasizes leveraging AI and large-scale human data to create precision therapeutics that target the root causes of metabolic dysfunctions. Target clients include individuals suffering from obesity, pediatric obesity, metabolic dysfunction-related conditions, and neurological disorders, as well as the broader medical community seeking transformative treatment solutions.Read More